Multivessel TALENT

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,550

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Coronary Artery DiseaseMyocardial IschemiaCoronary DiseaseHeart DiseasesCardiovascular DiseasesArterial Occlusive DiseasesVascular Diseases
Interventions
DEVICE

SUPRAFLEX Cruz

Percutaneous Coronary Intervention for multivessel disease

DEVICE

SYNERGY

Percutaneous Coronary Intervention for multivessel disease

Trial Locations (1)

H91 TK33

NUIG, Galway

All Listed Sponsors
lead

National University of Ireland, Galway, Ireland

OTHER